Healthcare Blogs

  Botulinum Toxin Market Highlights The botulinum toxin market size is projected to reach USD 6.5 billion by 2030, at a CAGR of 11.80% from 2022 to 2030. Botulinum toxin is known as one of the most poisonous biological substances. It is a neurotoxin produced by the bacterium Clostridium botulinum. There are seven distinct forms of botulinum toxin, types A–G. Four of these (types A, B, E, and rarely F) cause human botulism. Botulinum toxin A and B are used for therapeutic and aesthetic procedures. The increasing cases of spasticity, cervical dystonia and chronic migraine, surge in demand for facial aesthetic, and rising number of product launches and approvals by key players are likely to drive the growth of the global botulinum toxin market trends during the forecast period. Segment Analysis The Global Botulinum Toxin Market insights , by type, has been segmented into botulinum toxin type A and B.   Rising adoption of botulinum toxin in aesthetic procedures as compare...

  Internet of Things in Healthcare Market Highlights According to MRFR analysis, the Internet of Things (IOT) in healthcare market is expected to cross USD 632.53 billion by 2030 at a CAGR of ~25.50%. The global IoT in healthcare market trends is driven by several factors, such as increasing adoption of wearables to measure vitals regularly, rising mental and physical health awareness among the young population, growing telemedicine sector, and rising demand for remote monitoring systems. In addition, the emergence of implantable monitoring systems, ingestible sensors, and connected smart contact lenses is also creating new opportunities for the market. These monitoring and tracking systems analyse the vitals and notify the patient of the next drug dose. Moreover, the introduction of smart hospitals across the globe is generating possibilities for the deployment of IoT-based devices. This will enable medical staff to accelerate the processing of patient data, better drug and m...

  CBD Oil Market Highlights The  CBD Oil Market  is estimated to be valued at  USD 3.78 Billion by 2027  and expected to grow at a  CAGR of 32%  during the forecast period .  CBD is a cannabinoid found in the cannabis plant. CBD oil acts as a natural pain reliever, have anti-inflammatory properties and could reduce epileptic seizures, etc. From the past few years, the market for CBD oil market had been increasing owing to rising legalization of cannabis and growing R&D in the field. Following the same, it is noted that new market players have been emerging in the market owing to the rising demand for CBD oil. Regional Analysis The  CBD oil market outlook in the Americas has been segmented into North America and Latin America. The North American market is further divided into the US, Canada, and Mexico. The Americas dominate the global CBD oil market, owing to the increasing consumption of cannabis-based products. According t...

  Cell Viability Assays Market Highlights The imperative factor driving the global cell viability assays market growth is the growing prevalence of chronic ailments and infectious diseases. Other important factors aiding the market growth include growing availability of funds for cell-based research, increasing focus on developing cell-based therapeutics, and the rising need of cell-based assays in research and development (R&D) activities. Cell Viability Assays Market Overview and analysis by product, cell type, application, end-user, forecast till 2030. Cell viability assays is a type of technique that is used for determining viable cells in the culture. Market Research Future (MRFR) has published a research report about the global cell viability assays market is anticipated to reach USD 3.83 billion by 2030 at 8.50% CAGR during the forecast period 2022-2030. Market Regional Analysis The regional segmentation of the global cell viability assays market insights has s...

  Blood Flow Measurement Devices Market Highlights Blood flow measurement devices are measurement devices that are used by the physician to understand the nature of the blood flow such as the amount of blood supplied to various vital organs and abnormal changes in the blood flow velocity, which can cause malformation of vessels. Blood Flow Measurement Devices Market Size was valued at USD 0.2 billion in 2022. The Blood Flow Measurement Devices market industry is projected to grow from USD 0.217 Billion in 2023 to USD 0.36 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8% during the forecast period (2023 - 2030). The growth of the market is due to the increasing cardiovascular disorders, increasing obesity rates, and growing demand for minimally invasive procedures. Entering the untapped market is an opportunity for the blood flow measurement devices market. Similarly, the high cost of the devices and lack of skilled professionals can hamper the growth ...

  Insulin Biosimilars Market Highlights A disease in which the body’s ability to produce or respond to the hormone insulin is impaired, resulting in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood is termed diabetes. Biosimilar insulin is designed to be highly like the original, or reference, insulin product described in a patent. As patents for major branded insulin products start to expire, several biosimilar insulin markets are expected to launch in the coming years. Insulin Biosimilars Market was valued at USD 2311 Million in 2019 and is expected to register a CAGR of14.80% during the forecast period of 2022 to 2030. The USFDA approved new insulin glargine Basilar, for type 1 and type 2 diabetes which is a biosimilar version of Sanofi’s basal insulin Lantus (insulin glargine). Additionally, Lilly and Boehringer Ingelheim’s biosimilar insulin glargine has got approval through the European Medicines Agency’s (EMA’s) Biosimilar pathway. Suc...

  Immunoassay Analyzers Market Scenario Immunoassay analyzers is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global immunoassay analyzers market is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. Furthermore, rapid development in diagnostic medical devices, increasing need for better drug treatment, and the increasing geriatric population had also fuelled the market’s growth. On the other hand, high cost of instruments and poor reimbursement policies may restrain this growth during the forecasted period.  The Immunoassay Analyzers Market is anticipated to reach USD 1,588.16 Million by 2030 at 5.40% CAGR during the forecast period 2022-2030. ...